ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,551Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1269

$692K Total Retail Price of All Prescriptions

Rank: 57 out of 1269

494 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,459 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 423 364 1 5
LEVOTHYROXINE SODIUM 345 326 2 4
WARFARIN SODIUM 331 312 3 12
SIMVASTATIN 314 245 4 3
AMLODIPINE BESYLATE 312 269 5 2
METOPROLOL TARTRATE 281 256 6 6
LISINOPRIL 275 232 7 1
OMEPRAZOLE 270 243 8 8
ALBUTEROL SULFATE 266 233 9 88
DONEPEZIL HCL 260 239 10 22
TRAMADOL HCL 256 221 11 16
SERTRALINE HCL 208 197 12 23
GABAPENTIN 183 146 13 17
MIRTAZAPINE 174 174 14 24
POTASSIUM CHLORIDE 157 152 15 26
KLOR-CON 10 155 103 16 122
METFORMIN HCL 155 136 16 9
IPRATROPIUM BROMIDE 152 143 18 127
RANITIDINE HCL 149 144 19 27
HUMALOG 146 93 20 109
RISPERIDONE 144 118 21 43
CITALOPRAM HBR 139 117 22 21
NAMENDA 126 112 23 38
ALENDRONATE SODIUM 123 105 24 28
LACTULOSE 120 49 25 67
PANTOPRAZOLE SODIUM 114 112 26 18
POLYETHYLENE GLYCOL 3350 112 86 27 50
CARVEDILOL 110 95 28 29
KLOR-CON M20 108 95 29 60
JANUVIA 104 59 30 74
LEVETIRACETAM 101 47 31 55
LANTUS 85 48 32 39
PREDNISONE 84 76 33 45
TRAZODONE HCL 83 61 34 36
PRAVASTATIN SODIUM 82 62 35 11
ATORVASTATIN CALCIUM 78 77 36 7
AZITHROMYCIN 75 65 37 42
ALLOPURINOL 75 63 37 49
ISOSORBIDE MONONITRATE ER 75 72 37 63
ADVAIR DISKUS 74 71 40 46
CLOPIDOGREL 74 73 40 32
CIPROFLOXACIN HCL 73 57 42 66
BACLOFEN 72 45 43 103
LOSARTAN POTASSIUM 70 41 44 15
LIDODERM 69 68 45 56
LATANOPROST 68 57 46 143
FENTANYL 67 65 S2 47 105
ATENOLOL 65 49 48 14
METOPROLOL SUCCINATE 65 49 48 13
CLONIDINE HCL 63 50 50 51
CELEBREX 63 52 50 95
LABETALOL HCL 63 39 50 160
CYMBALTA 62 37 53 70
HYDROCHLOROTHIAZIDE 59 55 54 10
PLAVIX 57 57 55 47
SPIRIVA 57 52 55 64
ENALAPRIL MALEATE 54 53 57 79
BRIMONIDINE TARTRATE 53 35 58 205
NYSTATIN 53 50 58 119
DIVALPROEX SODIUM ER 52 19 60 176
METRONIDAZOLE 51 44 61 275
OXYCODONE-ACETAMINOPHEN 50 47 S2 62 44
CRESTOR 50 46 62 25
BENZTROPINE MESYLATE 50 34 R 62 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.